Dear IMS Member: We hope you are well during these difficult times. As a response to the current pandemic, the International Myeloma Society has developed the following Recommendations for anti-Covid-19 vaccination in patients with multiple myeloma (MM) and related conditions, AL amyloidosis and other monoclonal gammopathies of clinical significance.

These recommendations will help guide vaccination decisions for your patients with plasma cell disorder. Please follow as appropriate for your practice and patient needs as well as local conditions and governmental directions. The International Myeloma Society remains committed to keeping patients and physicians safe while providing care and treatment under these extraordinary circumstances.

We wish you well and be safe.

IMS Executive Committee